optimal lymphodepletion in car-t therapy recipients
Published 2 years ago • 114 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
4:44
optimizing lymphodepletion chemotherapy in car-t therapy recipients
-
3:31
the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
2:10
optimizing car-t therapy in lbcl
-
1:15
the current status and future of car-t therapy in r/r myeloma
-
2:06
the optimal sequencing of car-t and other immunotherapies in multiple myeloma
-
1:52
perspectives on patient selection for car-t therapy
-
1:32
the role of autosct in waldenström's macroglobulinemia and eligibility criteria
-
3:10
universal car-t therapy for t-all
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
2:04
the evolving role of car-t therapy in cll
-
1:38
challenges of car-t therapy in the real-world setting
-
0:51
developing universal car-t therapies for t-all
-
2:17
the challenges of implementing car-t therapy in cll
-
2:11
exploring strategies to mitigate t-cell exhaustion: treatment-free intervals & small molecules
-
1:51
regulatory and commercialization challenges with car t-cell therapy
-
1:42
challenges associated with car-t cell production
-
1:39
the role of myeloid cells in car-t cell therapy